J & J Vaccine 85% Efficacious Against Severe COVID Globally J & J Vaccine 85% Efficacious Against Severe COVID Globally

Despite a lower overall efficacy vs the mRNA vaccines, officials point out the Janssen vaccine prevented most severe disease and all hospitalizations and deaths in first Phase 3 results and is 72% efficacious against moderate-to-severe illness in the US.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news